Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in schwannomas: the chosen clone matters.

Creytens, David;Van Bockstal, Mieke;Ferdinande, Liesbeth;Van Dorpe, Jo
(2018) Human Pathology — Vol. 76, p. 167-168 (2018)

Files

2018_Creytens_Human_Pathol.pdf
  • Open Access
  • Adobe PDF
  • 100.18 KB

Details

Authors
  • Creytens, David
    Author
  • Author
  • Ferdinande, Liesbeth
    Author
  • Van Dorpe, Jo
    Author
Abstract
(en) To the Editor: We have read with great interest the recently published study by Wang et al [1] on aberrant expression of thyroid transcription factor-1 (TTF-1) in schwannomas. The authors described nuclear TTF-1 in 109 (67.7%) schwannomas, including 102 of 132 (77.9%) conventional, 1 of 20 (5%) cellular, and 6 of 10 (60%) plexiform schwannomas. Nuclear staining was not identified in normal peripheral nerves and nonschwannoma peripheral nervous system lesions. [...]
Affiliations
  • Erasmus Medical Center RotterdamDepartment of Pathology

Citations

Creytens, D., Van Bockstal, M., Ferdinande, L., & Van Dorpe, J. (2018). Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in schwannomas: the chosen clone matters. Human Pathology, 76, 167-168. https://doi.org/10.1016/j.humpath.2018.02.026 (Original work published 2018)